China Intl Capital Corp Ltd (3908)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 20 Oct 2026
Key indicators
| Last close | HKD 18.34 |
|---|---|
| 52-week range | 16.69 – 23.30 |
| Return, 1 month / 3 months | −6.5% / −16.2% |
| Return, 1 year / 3 years | −10.3% / +24.0% |
| Trend | Below its 200-day average |
| RSI (14) | 34 |
| Volatility (1 year) | 39.6% |
| Worst drawdown (1 year) | -25.8% |
| Average daily value traded | 310.34M HKD |
| Dividend yield | 2.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
China International Capital Corporation is an investment bank based in Beijing. It advises companies on mergers and acquisitions, helps them raise money through offerings of equity and debt, and provides securities brokerage and asset management services. Its clients are mainly large enterprises, financial institutions and institutional investors, both within China and internationally. The firm also carries out research and trading activities for professional investors, and it operates through offices in major financial centres.
On this site China Intl Capital Corp Ltd appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 3908, with prices in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
China Intl Capital Corp Ltd (3908) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 18.34 on 20 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 514 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.3% and over the last three months it fell 16.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -9.7% | ||
| From 52-week high | -19.8% | ||
| Momentum | 50 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -16.2% | ||
| 6-month return | -6.3% | ||
| 12-month return, skipping the last month | -4.1% | ||
| Stability (higher is calmer) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.8% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 310.34M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 38 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.0% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −7.5% |
|---|---|
| 1 month | −6.5% |
| 3 months | −16.2% |
| 6 months | −6.3% |
| 1 year | −10.3% |
| 3 years | +24.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 20.51 / 20.31 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.69 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Jun 2026 | HKD 0.2645 |
| 4 Nov 2025 | HKD 0.0987 |
| 2 Jul 2025 | HKD 0.0986 |
| 4 Nov 2024 | HKD 0.0981 |
| 3 Jul 2024 | HKD 0.1973 |
| 4 Jul 2023 | HKD 0.1956 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.